Frequently Asked Questions About CSURE.TA

What does Cannassure Therapeutics Ltd do?

Cannassure Therapeutics Ltd (CSURE.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is CSURE.TA's market cap?

Cannassure Therapeutics Ltd (CSURE.TA) has a market capitalization of approximately $2.21 billion, as of July 16, 2023, based on the most recent share price and shares outstanding.

Does CSURE.TA pay a dividend?

No — Cannassure Therapeutics Ltd (CSURE.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is CSURE.TA profitable?

Cannassure Therapeutics Ltd (CSURE.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

CSURE.TA (Cannassure Therapeutics Ltd) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

CSURE.TA

Cannassure Therapeutics Ltd

TLV·Biotechnology · Healthcare

ILA 43.20ILA 0.70+1.65%

Market capILA 2.21B·Jul 16 11:50 AM UTC

Price Chart

ILA 43.20+ILA 0.70 (+1.65%)today

+581.39%CAGR +46.79%

Select date range

FromTo

Jan 16, 2019Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

CSURE.TA does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateFeb 15

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how CSURE.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CSURE.TA and 80,000+ other tickers.

About Cannassure Therapeutics Ltd

Cannassure Therapeutics Ltd specializes in the cultivation and production of medical cannabis. Its diverse product portfolio features medical cannabis oils, a range of inflorescences including indoor, select, and value varieties, and cannavix. The company, established in 2016, is headquartered in Ashdod, Israel.

Sector: Healthcare
Industry: Biotechnology
Exchange: TLV

Peers

Peers Tab

BCUR.TA

Erika B-Cure Laser Ltd

Cap

ILA 1.7B

AMDA.TA

Almeda Ventures Limited Partnership

Latest News

News Tab

No recent news available.

Frequently Asked Questions About CSURE.TA

What does Cannassure Therapeutics Ltd do?: Cannassure Therapeutics Ltd (CSURE.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is CSURE.TA's market cap?: Cannassure Therapeutics Ltd (CSURE.TA) has a market capitalization of approximately $2.21 billion, as of July 16, 2023, based on the most recent share price and shares outstanding.
Does CSURE.TA pay a dividend?: No — Cannassure Therapeutics Ltd (CSURE.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is CSURE.TA profitable?: Cannassure Therapeutics Ltd (CSURE.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.